跳至主要内容
临床试验/CTRI/2016/03/006716
CTRI/2016/03/006716进行中(未招募)未知

An observational, multi-centric study to investigate microbial diversity of human gut of Indian population â?? A PAN India study.

TATA Chemicals0 个研究点目标入组 1,000 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Age 18 to 65 years
  • 2.to sign subject authorization form
  • 3.Does not have any Willing disease (eg. chronic diarrhea, inflammatory bowel disease, irritable bowel syndrome, or other gastrointestinal disorder, gastrointestinal surgery [except appendectomy, polypectomy, or herniorraphy], or severe chronic illness such as major organ failure, diabetes, acquired immunodeficiency syndrome) that may hamper the subject participation in the study as per investigatorâ??s discretion
  • 4.Adequately understand the instructions provided by the site personnel regarding stool collection procedure

排除标准

  • 1.Prescription or over-the-counter medications or supplements that are known to alter gut function or microflora (i.e. acid antisecretory drugs, probiotics) during the past 4 weeks prior to study enrolment

研究者

发起方
TATA Chemicals

相似试验

An observational study to collect data on microbial... | 临床试验